MidCap Arranges Facility to Support MTS Health Investors Buy
MidCap Financial announced that it served as joint lead arranger, joint bookrunner and syndication agent for a $65 million senior secured credit facility in support of support of Celerion’s MTS Health Investors acquisition.
New York-based MTS is a healthcare private equity firm that makes investments in operating companies within services sectors of the healthcare industry.
“We are very excited to support MTS’s acquisition of Celerion,” said Josh Rothenberg, director at MidCap. “MTS is an ideal sponsor for Celerion given its track record and experience in the healthcare industry, and we believe Celerion is well positioned to continue its growth as a leader in early-stage clinical research, a market we view favorably.”
Lincoln, NE-based Celerion provides early stage clinical research solutions to pharmaceutical, biotechnology and generic drug companies.